Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The primary objective is to determine if the opioid properties of ketamine are responsible for its antidepressant effects. Since naltrexone can block opiate actions, the investigators will determine if naltrexone can effectively block ketamine\'s effects.
Epistemonikos ID: c9fcaa959ccc48c0a982b8c49f543056850853f6
First added on: May 17, 2024